Henry Ford Health + Michigan State University Health Sciences has named the award recipients of the 2024 Cancer Seed Funding Program. Building on the success of the 2022 and 2023 cancer research pilot and integration award funding initiatives, this year the program awarded 14 new cancer research awards totaling $700,000.
“We are committed to supporting collaborative research to create a national and international destination for access to the most advanced cancer therapies and interventions,” said Ben Movsas, Henry Ford + MSU Cancer Committee co-chair, Henry Ford Cancer medical director and radiation oncology chair. “Our Henry Ford + MSU cancer researchers are demonstrating the power of coming together, with examples of previous recipients moving forward with federally funded research proposals.”
Over the last three years, Henry Ford + MSU has provided a total of $2.7 million through the Cancer Seed Funding Program. Each award includes a principal investigator from Michigan State University and a principal investigator from Henry Ford Health.
“One of our primary goals is to close the gap in health care outcomes for cancer patients based on race, ethnicity, gender and socioeconomic status,” said Jeff MacKeigan, Henry Ford + MSU Cancer Committee co-chair and MSU Office of Research and Innovation senior advisor.
With more than a third of the awards focusing on health disparities, Henry Ford + MSU has also selected unique and collaborative proposals that combine the clinical and scientific strengths of both organizations. In addition, the proposals provided foundational support to advance collaborative cancer projects toward an NCI grant application.
The topic for this year’s program was Future NCI Grant Application. The recipients of the 2024 Cancer Seed Funding Program are listed below:
Get the latest updates on our programs and initiatives.
